◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
SymBio Pharmaceuticals Limited — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 04, 2025Q4 2024Dec 31, 2024Q3 2024Aug 02, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
+Operating Income -1.7B -- -49.7M -- -- --
Operating Margin % 116.1% -- -74.3% -- -- --
+Ordinary Income -1.5B -- 66.9M -- -- --
Revenue Growth % -- -- -- -- -- --
Line ItemQ3 2025Aug 04, 2025Q4 2024Dec 31, 2024Q3 2024Aug 02, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
Current Assets 4.9B -- 8.1B -- -- --
Total Assets 5.0B 7.7B 8.2B 9.4B 8.3B 6.2B
Current Liabilities 766.2M -- 956.6M -- -- --
Total Liabilities 770.8M 718.4M 960.3M 823.2M 1.4B 1.2B
Total Equity 4.2B 7.0B 7.2B 8.5B 6.8B 5.0B
Equity Ratio -- 0.87 -- 0.87 0.77 0.73
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...